Medlab Clinical Statistics
Total Valuation
MDLB has a market cap or net worth of $18.16 million. The enterprise value is $14.09 million.
| Market Cap | 18.16M |
| Enterprise Value | 14.09M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
MDLB has 4.08 million shares outstanding.
| Shares Outstanding | 4.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.82 |
| Forward PS | n/a |
| PB Ratio | 2.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -125.40 |
Financial Efficiency
Return on equity (ROE) is -93.29% and return on invested capital (ROIC) is -146.35%.
| Return on Equity (ROE) | -93.29% |
| Return on Assets (ROA) | -63.60% |
| Return on Capital (ROIC) | -146.35% |
| Revenue Per Employee | $36,580 |
| Profits Per Employee | -$170,534 |
| Employee Count | 42 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MDLB had revenue of $1.54 million and -$7.16 million in losses. Loss per share was -$1.75.
| Revenue | 1.54M |
| Gross Profit | 1.20M |
| Operating Income | -12.98M |
| Pretax Income | -7.16M |
| Net Income | -7.16M |
| EBITDA | -6.32M |
| EBIT | -7.17M |
| Loss Per Share | -$1.75 |
Balance Sheet
The company has $5.19 million in cash and $1.12 million in debt, giving a net cash position of $4.07 million or $1.00 per share.
| Cash & Cash Equivalents | 5.19M |
| Total Debt | 1.12M |
| Net Cash | 4.07M |
| Net Cash Per Share | $1.00 |
| Equity / Book Value | 7.75M |
| Book Value Per Share | 1.90 |
| Working Capital | 6.75M |
Cash Flow
In the last 12 months, operating cash flow was -$9.41 million and capital expenditures -$31,135, giving a free cash flow of -$9.44 million.
| Operating Cash Flow | -9.41M |
| Capital Expenditures | -31,135 |
| Free Cash Flow | -9.44M |
| FCF Per Share | -$2.31 |
Margins
Gross margin is 78.11%, with operating and profit margins of -845.13% and -466.19%.
| Gross Margin | 78.11% |
| Operating Margin | -845.13% |
| Pretax Margin | -466.19% |
| Profit Margin | -466.19% |
| EBITDA Margin | -411.42% |
| EBIT Margin | -466.79% |
| FCF Margin | -614.57% |
Dividends & Yields
MDLB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -39.44% |
| FCF Yield | -51.99% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDLB has an Altman Z-Score of -5.55. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.55 |
| Piotroski F-Score | n/a |